Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Alamar Biosciences announced a partnership with leading research universities to launch a national-scale proteomics initiative profiling approximately 21,000 plasma samples from 10,000 Alzheimer's Disease and Related Dementias participants using its NULISAseq Neuro 220 panel. The resulting dataset will be publicly accessible and open to AI-driven discovery through a national data challenge, advancing biomarker discovery for neurodegenerative diseases.